Literature DB >> 1677243

Hepatobiliary complications of polyarteritis nodosa.

S Parangi1, M C Oz, R S Blume, R Bixon, K J Laffey, K H Perzin, J A Buda, A M Markowitz, R Nowygrod.   

Abstract

Although polyarteritis nodosa (PAN) may result in thrombosis or aneurysm formation in any organ in the body, hepatobiliary complications are unusual. We reviewed seven cases that demonstrated the diagnostic difficulties and therapeutic options available in the management of hepatobiliary PAN. No consistent sign that indicated the severity of hepatobiliary PAN could be identified. In cases of thrombotic PAN, acalculus cholecystitis usually could be diagnosed preoperatively. Early tissue diagnosis and aggressive intervention are required for appropriate patient treatment. If the diagnosis is unclear, a preoperative muscle or skin biopsy specimen is often helpful in establishing a tissue diagnosis of PAN, even if no obvious pathologic condition is evident. Patients who undergo celiotomy for acalculus cholecystitis or peritoneal signs of an unclear origin should have tissue specimens (gallbladder wall, liver, or omentum) submitted for pathologic study. Angiography may be diagnostic preoperatively or when results of biopsies are equivocal. In addition, early angiography can define the extent of visceral involvement and permit control by embolization of hemorrhage secondary to aneurysm rupture. Awareness of the possibilities of thrombotic, ischemic, or bleeding complications from PAN allows more aggressive and rapid management of abdominal complaints, especially in patients who are receiving immunosuppressant therapy.

Entities:  

Mesh:

Year:  1991        PMID: 1677243     DOI: 10.1001/archsurg.1991.01410310119019

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

1.  Polyarteritis nodosa presented as a dilatation of the intrahepatic bile duct.

Authors:  Han Lim Choi; Ro Hyun Sung; Min Ho Kang; Hyun Jeong Jeon; Hyo Yung Yun; Lee Chan Jang; Jae Woon Choi; Young Jin Song; Dong Hee Ryu
Journal:  Ann Surg Treat Res       Date:  2014-10-24       Impact factor: 1.859

Review 2.  Aneurysms of the visceral and renal arteries.

Authors:  Y P Panayiotopoulos; R Assadourian; P R Taylor
Journal:  Ann R Coll Surg Engl       Date:  1996-09       Impact factor: 1.891

3.  Reactive hemophagocytic syndrome in a patient with polyarteritis nodosa associated with Epstein-Barr virus reactivation.

Authors:  Ikuko Hayakawa; Fumiaki Shirasaki; Hiroko Ikeda; Naoto Oishi; Minoru Hasegawa; Shinichi Sato; Kazuhiko Takehara
Journal:  Rheumatol Int       Date:  2006-04       Impact factor: 2.631

4.  Clinical predictors of severe gallbladder complications in acute acalculous cholecystitis.

Authors:  Ay-Jiun Wang; Tsang-En Wang; Ching-Chung Lin; Shee-Chan Lin; Shou-Chuan Shih
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

5.  A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizations.

Authors:  Servet Akar; Yigit Goktay; Baris Akinci; Dilek Tekis; Kadir Biberoglu; Merih Birlik; Fatos Onen; Mehmet Tunca; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-01-08       Impact factor: 2.631

6.  An unusual case of acalculous cholecystitis heralding presentation of acute mesenteric ischaemia with typical radiological findings.

Authors:  Emma Aitken; Alison Lyon; Itamar Felstenstein
Journal:  Int J Surg Case Rep       Date:  2012-04-17

7.  Hemobilia from ruptured hepatic artery aneurysm in polyarteritis nodosa.

Authors:  Sung Soon Park; Byeong Uk Kim; Hye Suk Han; Ja Chung Goo; Joung Ho Han; Il Hun Bae; Seon Mee Park
Journal:  Korean J Intern Med       Date:  2006-03       Impact factor: 2.884

8.  Single-organ gallbladder vasculitis: characterization and distinction from systemic vasculitis involving the gallbladder. An analysis of 61 patients.

Authors:  José Hernández-Rodríguez; Carmela D Tan; E René Rodríguez; Gary S Hoffman
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.